Capital Fund Management S.A. United Therapeutics Corp Call Options Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 13, 2020	SELL	$79.39 - $115.35 $222,292 - $322,980	-2,800 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$78.31 - $95.34 $219,268 - $266,952	2,800 New	2,800 $247,000
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $232,034 - $266,569	-3,100 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$76.06 - $120.81 $83,666 - $132,891	1,100 Added 55.0%	3,100 $242,000
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $740,220 - $939,728	-7,300 Reduced 78.49%	2,000 $218,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $997,053 - $1.41 Million	9,300 New	9,300 $1.05 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.